Pharmacopsychiatry

Article	Citations
	70
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?	26
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study	24
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry	22
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study	22
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries	20
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System	17
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation	16
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination	15
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model	15
The Mini-TRH Test	13
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety	13
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study	12
Psychiatric syndromes associated with anti-neural autoantibodies differ in their affective psychopathology from those that are not	10
Neutral sphingomyelinase is a major driver of sex-differences in depression and alcohol-abuse	9
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS	8
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA	8
	8
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response	7
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation	7
Mineralocorticoid and glutamatergic NMDA receptor stimulation does not influence spatial learning and memory in depressed individuals and healthy control	7
	7
News on the Role of Antidepressants in and for COVID-19 and Long COVID	7
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie	6
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy	6

Patient and Physician Exposure to Artificial Intelligence Hype	6
	6
Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting	6
Vitamin D: Adjustment of Per1 expression in study participants with an ADHD diagnosis	5
	5
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey	5
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factor	5
Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case	5
	5
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis	4
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use	4
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab	4
	4
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita	4
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorde	4
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes	4
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials	4
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review	3
	3
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?	3
Overview: Chronic Pain and Cannabis-Based Medicines	3
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs	3
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics	3
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye	2
Major depressive episodes with high rapid eye movement density do not respond better to rapid eye movement sleep suppressive antidepressants than to others	2
A retrospective comparison of etomidate and methohexital as anesthetic agents for maintenance electroconvulsive therapy	2
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme	2
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges	2
Metformin is Protective Against the Development of Mood Disorders	2
	2
	2
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa	2
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality	2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie	2
How valid are therapeutic reference ranges for psychotropic drugs?	2
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA	1
Antipsychotic Polypharmacy and Epigenetic Age Acceleration in Schizophrenia	1
Early Treatment-Resistance in First Episode Psychosis	1
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression	1
Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schiz	1
Antidepressants in pregnancy – focus on therapeutic drug monitoring	1
Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation	1
The relevance of TDM for long-acting injectable antipsychotics	1
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders	1
Functional connectivity analysis of locus coeruleus in patients with major depressive episode	1
	1
Mood stabilizers during pregnancy – significance of therapeutic drug monitoring	1
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis	1
Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model	1
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring	1

QTc interval alterations during antidepressant treatment with escitalopram and venlafaxine	1
Investigation of Stress-Induced Cortisol Effects on Decision Making After Pharmacological Mineralocorticoid or Glucocorticoid Receptor Blockade	1
	0
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?	0
Investigation of axonal neurodegeneration in anti-neural autoantibody-associated psychiatric syndromes	0
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range	0
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review	0
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy	0
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment	0
Morphological Representation of C1q in the Aging Central Nervous System	0
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range	0
Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression	0
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients	0
Liquid Chromatography/Tandem Mass Spectrometry (LC-MSMS) Analysis of neuropsychiatric drugs: Challenges from the perspective of the laboratory physician	0
Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments	0
Lithium Therapy in Old Age: Recommendations from a Delphi Survey	0
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report	0
	0
Processing and recall of safety- and threat cues: The influence of oxytocin and the menstrual cycle	0
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study	0
Pharmacological Treatment of Autism Spectrum Disorder: A Systematic Review of Treatment Guidelines	0
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study	0
Clozapine-Induced Stuttering: Case Report and Literature Review	0
A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study	0
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder	0
Instruments Assessing Medication Literacy in Psychiatric Patients and the Caregivers: A Systematic Review	0
Neurological soft signs are increased in major depressive disorder irrespective of antidepressant treatment	0
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature	0
Caffeine influences Clock expression in study participants with an ADHD diagnosis	0
Age-dependent stimulus dose increase during an acute ECT series	0
Influence of long-term citalopram treatment on the cognitive decline and pathology in a sporadic Alzheimer’s disease mouse model	0
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years	0
Clomethiazole for insomnia in older adults: A systematic review and meta-analysis	0
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial	0
Implications of Online Self-Diagnosis in Psychiatry	0
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice	0
How to Improve Methodological Issues in Clinical Trials to Confirm that Pentoxifylline is Useful as an Add-on Therapy for Major Depressive Disorder	0
Classic Psychedelic Drugs: Update on Biological Mechanisms	0
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany	0
„Peter Müller Preis für Forschung im Bereich Schizophrenie“ in Höhe von 5.000€	0
Cortical and subcortical grey matter volume alterations in neuropsychiatric long-COVID syndrome episode	0
Association of Physical Activity and Bone Mineral Density in Adults with Depressive Symptoms	0
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis	0
Therapeutic drug monitoring of venlafaxine in real-world patients: Dose, concentration and therapeutic efficacy	0
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine	0
	0
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection	0
The therapeutic reference range for olanzapine revised – how to combine old and new findings	0
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis	0
Age-dependent sex differences in the association between cortisol concentrations and childhood trauma	0
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial	0
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment	0
Influences on therapeutic drug monitoring of psychotropic drugs – analyst's perspective	0
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major Depression	0
Medical Cannabis in Psychiatry	0
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review	0
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?	0
Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities	0
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation	0
Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?	0
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey	0
	0
Positive association between norfluoxetine serum concentration and prolonged QTc intervals in children and adolescents	0
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D	0
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinic	0
ADHD and oligoantigenic diet – Feasibility, effectiveness and follow-up	0
Therapeutic drug monitoring in relapse prevention of alcohol dependent patients	0
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedica	0
Discussion: Genotyping in real life setting	0
Is Lumateperone Effective in Bipolar Depression? A Systematic Literature Review and Meta-Analysis on Placebo-Controlled Trials	0
CYP2C19 and CYP2D6 genotyping in a cohort of patients with treatment-resistant depression	0
	0
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis	0
Triiodothyronine: Strengthened evening preference in study participants with an ADHD diagnosis	0
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response	0
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis	0
Ensemble Machine Learning Model for Real-Time Valproic Acid Prediction in Epilepsy Treatment	0
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine	0
Cannabinoids for Behavioral Symptoms in Dementia: An Overview	0
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integratio	0

Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series	0
	0
Covid-19: Contributions from Psychopharmacology	0
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multic	0
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point	0
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by therapeutic	0
	0
Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism	0
Low glucose influences Clock expression in study participants with an ADHD diagnosis	0
Drug interactions in patients undergoing opioid maintenance therapy	0
Using TDM data to study treatment failure	0
	0
	0
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy	0
Interleukine-6 and high-sensitive CRP plasma levels and antidepressant response- A secondary analysis from the Early Medication Change (EMC) trial	0
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic	0
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis	0
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, R	0
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study	0
Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review	0
The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms	0
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties	0
Caffeine augmentation in electroconvulsive therapy	0
	0
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Stu	0
	0
	0
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry	0
Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?	0
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism	0
Clomethiazole for the treatment of alcohol withdrawal syndrome: A systematic review and metanalysis	0
Therapeutic Reference Ranges for ADHD Drugs in Blood of Children and Adolescents: A Systematic Review by the AGNP TDM-Task Force	0
Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD	0
Traumatic childhood experiences are related to higher hair cortisol in postpartum	0
A compilation of serum concentrations of 12 antipsychotic drugs in a therapeutic drug monitoring setting	0
Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents	0
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia	0
Dose-corrected serum concentrations of antidepressant drugs in patients of a gerontopsychiatric day care unit – Dependence on renal function and multimorbidity?	0
Comparative study of suggested reference values and observed distributions in daily routine of a medical laboratory	0
Drawing new lines – Machine-learning guided response prediction and bio-signal analysis of ECT index series	0
COVID-19 Prognosis in Association with Antidepressant Use	0
„AGNP-Preis für Forschung in der Psychopharmakologie“ in Höhe von 5.000 €	0
Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments	0
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey	0
Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression	0
Patient Perspectives on Pharmacotherapy of Alcohol Dependence	0
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammati	0
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature	0
	0